Navigation Links
Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
Date:10/27/2008

ANTONY, France, October 27 /PRNewswire-FirstCall/ -- Stallergenes has just obtained authorization (IND(1)) from the FDA for immediately launching a phase III clinical trial in the United States with Oralair(R) Grasses in the treatment of allergic rhinoconjunctivitis to grass pollens in adults.

The aim of the study, which will be conducted in 450 American patients during the 2009 pollen season, is to confirm the efficacy and good tolerance of the product in adults and to support the application for authorization to market it in the United States.

"This IND application for a phase III study is testimony to our company's capacity to meet the FDA's requirements," states Albert Saporta, President & CEO of Stallergenes. "In order to reinforce our attractiveness as we look forward to the prospect of a US partnership for marketing Oralair(R), we are naturally conducting this development with Quintiles, our longstanding partner for all the post-phase I development of the Oralair program, i.e. seven phase IIb/III or III studies (studies already conducted and those still underway). There is no doubt that this combined cumulative experience gives us real expertise, which is crucial when it comes to setting up studies and interfacing with agencies, particularly the FDA."

"2009 will be an exceptional year, with the results of four major phase IIb/III or III clinical studies: the Oralair(R) Mites pivotal study, the Oralair(R) Birch pollen (rBet v 1) study, the Oralair(R) Grasses long term efficacy and this one about Oralair(R) grasses in the United States."

"All of these elements will enable us, when the time comes, to optimize the terms of a strategic partnership. The planned R&D investment levels are compatible with the operating income in value in 2009 remaining at its 2008 level."

About Oralair(R) Grasses

Oralair(R) Grasses is a fast-dissolving sublingual desensitization tablet indicated in the treatment of allergic rhinoconjunc
'/>"/>

SOURCE Stallergenes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
2. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
3. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
4. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
5. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
6. Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative
7. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
8. The MaxCyte STX Scalable Transfection System to be Launched at the SBS Symposium on Cell-Based Assays
9. HealthYes! - Premier Provider of Mobile Preventive Medical Screenings - Launches in Alamo City
10. Sensorin Raises Equity Financing to Launch Novel Industrial Sensing Venture
11. Video: OneTouch(R) Teams With Online Diabetes Community to Launch Global Diabetes Handprint Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Glendale, CA (PRWEB) May 21, 2013 ... researchers at the University of California, San Diego for ... of load bearing Gravitic™ MRI (Magnetic Resonance Imaging) with ... is renowned for its continued pursuit of improved healthcare ... , Spinal MRI is an extremely valuable tool for ...
(Date:5/21/2013)... Sunnyvale, CA (PRWEB) May 21, 2013 ... is an 8-week training program starting on June ... to help clinical trial professionals reach the next step ... at Dentons Offices in Palo Alto, and streamed online. ... author of award-winning papers, Clinovo's new “CDISC Standards: Theory ...
(Date:5/20/2013)... ANGELES , May 20, 2013 Today, ... San Francisco , James McGough ... Clinical Psychiatry at the Semel Institute for Neuroscience and ... of Medicine at the University of California Los ... both Child and Adolescent Psychopharmacology and ADHD at UCLA, ...
(Date:5/20/2013)... , Md. and BALTIMORE , ... (BHI), a regional private-public partnership focusing on ... early-stage funding in Central Maryland ... Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) for ... National Heart, Lung and Blood Institute ...
Breaking Biology Technology:Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3Clinovo Launches TechTrainings on CDISC Standards 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4
... Sept. 13Researchers at Vanderbilt University have developed a new technique ... biological tissue at multiple points simultaneously, a method that could ... grow and change shape. UV lasers are a ... make incisions by vaporizing one point at a time in ...
... FORT WORTH, Texas, Sept. 13, 2011 Healthpoint Biotherapeutics ... Operating Officer, and Robert Bancroft, Executive Vice President, Strategic ... Company, its commercial products and its R&D pipeline at ... is scheduled for the opening day of the conference, ...
... 2011 Microban recently conducted in vitro ... growth on High Consistency Rubber (HCR) silicone, which ... catheters.  Urinary infections are a costly source of ... had limited success in reducing infection rates. The ...
Cached Biology Technology:Healthpoint Biotherapeutics to Present at UBS Global Life Sciences Conference 2Microban Medical Silver Antimicrobial Technologies for HCR Silicone Achieve 5 Log Reductions in Bacteria Growth and Prevent Biofilm Formation 2
(Date:5/20/2013)... USA New Geology articles posted ... 2013 cover a wide swath of geoscience subdisciplines, ... geophysics, and paleobotany. Locations studied include Siberia; the ... Alpi Apuane, Italy; Ukraine; Mars; and the Southeastern ... 1. Rubies, jadeite, and plate tectonics;, 2. The ...
(Date:5/19/2013)... strain of electricity-producing bacteria that can grow using hydrogen ... as its sole source of carbon. Researchers at ... the 113th General Meeting of the American Society for ... production solely on hydrogen," says Amit Kumar, a researcher ... part of the Lovley Lab Group at the university. ...
(Date:5/18/2013)... The AGA Research Foundation is honored to announce ... in Digestive Cancer, which will support Andrew D. Rhim, ... University of Pennsylvania, Philadelphia, as he furthers his research ... and cancer progression. , "The AGA Research Foundation is ... distinguished clinicians and AGA Legacy Society members," said Nicholas ...
Breaking Biology News(10 mins):New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... Dec. 2, 2008 Presbycusis, or age-related hearing loss, ... why do some people lose their hearing as they get ... The answer may be in a study ... Advance access is available online at http://hmg.oxfordjournals.org/papbyrecent.dtl . ...
... Mercury levels in fish are prompting widespread consumption advisories ... to eat. Now researchers at North Carolina State University ... regulators around the country predict which areas are likely ... breakthrough that should help officials address public uncertainty by ...
... University,s Woods Institute for the Environment, The Nature ... a two-year, $1.97 million grant from the Gordon ... program for mapping and evaluating the economic benefits ... InVEST (Integrated Valuation of Ecosystem Services and Tradeoffs), ...
Cached Biology News:House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss 2New model predicts hot spots for mercury in fish 2Natural Capital Project to develop conservation software 2
... IgG FITC is used as the ... on tissues or culture cells where ... rabbits. It is highly recommended that ... the primary antibody, be included in ...
1000X solution used for inducing CopyControl™ based vectors to high copy numbers...
Request Info...
HAS1 (C-14)...
Biology Products: